MedElevator Войти в исследования
← Поиск публикаций

DOI 10.3389/fcell.2026.1744708

Медицинская библиотека · Frontiers in cell and developmental biology · 2026

Circulating exosomal miR-550a-5p/miR-665 identify coronary microvascular dysfunction and drive endothelial-myocyte crosstalk in type 2 diabetes.

Ding Xiudong, Bai Guangliang, Liu Xin, Dong Yueming, Chai Yinghui, Han Bing, Meng Xianghong, Lei Hong

СтатьяПеревод пока не подготовлен

Аннотация

OBJECTIVE

This study aimed to identify circulating exosomal microRNAs for early detection of coronary microvascular dysfunction (MD) and stratification of myocardial injury risk in type 2 diabetes, and to test whether miR-550a-5p derived from endothelial cell models mechanistically links endothelial stress to cardiomyocyte vulnerability via Hippo-eNOS signaling and vesicular transfer.

METHOD: We combined Gene Expression Omnibus (GEO)-guided discovery and compendium prioritization with clinical and mechanistic validation. Plasma exosomal miR-550a-5p/miR-665 were quantified in a well-phenotyped Type 2 Diabetes Mellitus (T2DM) cohort and related to MD and myocardial injury. In vitro, miR-550a-5p was modulated in human cardiac microvascular endothelial cells under high glucose to profile Hippo-YAP/eNOS signaling, and its exosomal transfer effects on human cardiomyocytes were evaluated, with Hippo inhibition applied as a rescue strategy.

RESULT: Exosomal miR-550a-5p and miR-665 were elevated in MD and further increased with myocardial injury, showing useful diagnostic performance and independent associations. miR-550a-5p inhibition restored endothelial viability, migration, tube formation and p-eNOS/eNOS, reduced MST1/LATS1 activation, and increased Yes-associated protein (YAP) activity. Endothelial exosomes delivered miR-550a-5p to cardiomyocytes, aggravating apoptosis and oxidative stress; donor-cell miR-550a-5p suppression and Hippo inhibition mitigated these effects.

CONCLUSION

Exosomal miR-550a-5p, together with miR-665, functions as a dual-utility signal, serving as an accessible biomarker for coronary MD and as a mechanistic mediator in endothelial-to-cardiomyocyte exosomal signaling. These findings support earlier detection, risk stratification, and mechanism-guided intervention in T2DM. Future priorities include external validation, longitudinal kinetic assessment, and target-network mapping.

Для цитирования: Ding Xiudong, Bai Guangliang, Liu Xin, Dong Yueming, Chai Yinghui, Han Bing, Meng Xianghong, Lei Hong. Circulating exosomal miR-550a-5p/miR-665 identify coronary microvascular dysfunction and drive endothelial-myocyte crosstalk in type 2 diabetes.. Frontiers in cell and developmental biology. 2026. DOI: 10.3389/fcell.2026.1744708.
Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.